Colleen E. Annesley, MD

Articles by Colleen E. Annesley, MD

Colleen E. Annesley, MD, on Continued Research With T-APCs to Enhance Cell Therapy Persistence

December 18th 2023

The medical Director and interim co-Chief Medical Officer at Seattle Children's Therapeutics discussed possible research to move forward with CD19 T-APCs for patients with B-ALL.

Colleen E. Annesley, MD, on Working to Mitigate Inferior Cell Persistence With Manufactured T-APCs

ByColleen E. Annesley, MD

December 11th 2023

The medical Director and interim co-Chief Medical Officer at Seattle Children's Therapeutics discussed complete data from the PLAT-03 feasibility trial assessing SCRI-CAR19 and CD19t T-APCs in B-ALL.

Colleen E. Annesley, MD

Articles by Colleen E. Annesley, MD

Colleen E. Annesley, MD, on Continued Research With T-APCs to Enhance Cell Therapy Persistence

Colleen E. Annesley, MD, on Working to Mitigate Inferior Cell Persistence With Manufactured T-APCs

Latest Updated Articles